FDAClass IIDecember 28, 2022

Quinapril Tablets USP recall: Impurity Out of Spec

Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403…

Why was Quinapril Tablets USP recalled?

CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: G102929, Exp 04/2023

Product
Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403…
Recalling firm
Lupin Pharmaceuticals Inc.
Quantity
23,736
Distribution
Product was distributed by major distribution chains nationwide.
Recall date
December 28, 2022
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls